09 Jan

[Blog] Traceability of Medicines in Egypt: A Practical Guide to Serialization and Track & Trace Compliance

Table of Contents

Traceability of Medicines in Egypt: A Practical Guide to Serialization and Track & Trace Compliance

In recent months, several pharmaceutical companies preparing exports to Egypt raised the same concern during readiness discussions: “We already serialize – are we actually compliant for Egypt?”

In one case, a shipment was fully serialized and aggregated, yet held because EPCIS events were uploaded in the wrong sequence. The issue was not the code on the pack, but how data was reported.

This example reflects a broader reality. The traceability of medicines in Egypt is no longer a documentation exercise. It directly affects release timelines, shipments, and market access. With the Egyptian Drug Authority enforcing a unified national track and trace system, pharmaceutical companies must ensure that serialization, aggregation, and real-time data reporting operate as one connected process.

Regulatory Framework and Scope

Egypt’s pharmaceutical track and trace system is regulated under Ministerial Decree No. 804/2025 and supervised by the Egyptian Drug Authority (EDA). The regulation establishes a Unified National Electronic System for Pharmaceutical Track and Trace.

Scope of application:

All finished human and biological medicines
Locally manufactured, locally packed, and imported products
All supply chain stakeholders: MAHs, manufacturers, importers, distributors, warehouses, and logistics providers

Mandatory deadlines:

February 1, 2026: Imported finished medicines
August 1, 2026: Locally produced or packed finished medicines

From these dates, non-compliant products may not circulate on the Egyptian market.

What is traceability of medicines in Egypt?

Traceability of medicines in Egypt is a national system that assigns a unique serial number to every medicine pack and records its movement across manufacturing, importation, storage, and distribution. Using EPCIS-based reporting, all supply chain events are transmitted in real time to ensure product authenticity, transparency, and regulatory oversight.

Serialization Requirements for the Egyptian Market

Each saleable unit must carry a 2D Data Matrix printed on the outer packaging. The code must include:

GTIN (Trade Item Number)
Unique Serial Number
Batch Number
Expiry Date Aggregation is mandatory. Individual packs must be linked to cartons and pallets using SSCC codes, ensuring continuity of tracking throughout the supply chain.For imports, a temporary allowance for NFC labels exists during the transition period. However, direct 2D Data Matrix printing becomes mandatory by August 2026.

EPCIS Reporting and System Integration

Egypt’s national system is built on EPCIS standards, requiring structured, event-based reporting.Key EPCIS principles:

Events must follow a defined sequence (Commissioning → Packing → Shipping → Receiving)
Data must be transmitted in real time
Delayed or batch uploads are not permitted
Receiving entities must be accurately identified at shipping events

Companies must integrate their ERP, MES, and serialization systems with the national platform. Each logistical location must have a registered location code, and financial transactions (such as sales invoices) must be linked to traceability events.

Obligations for Manufacturers and Importers

Manufacturers must:

Prevent duplication of GTIN and serial number combinations
Record commissioning and packing events without disrupting production
Implement aggregation across all packaging levels
Maintain continuous connectivity with the national system
Support toll manufacturing with shared compliance responsibility

Importers must:

Ensure compliant coding before shipment to Egypt
Receive EPCIS files from exporters prior to dispatch
Upload shipment data before arrival
Record receiving events upon entry into Egypt
Track all intermediate storage and warehouse movements

Operational and integration costs are borne by the responsible entities.

Penalties for Non-Compliance

EDA has the authority to enforce compliance through inspection and audit. In cases of non-compliance, authorities may apply:

Formal written warnings
Temporary suspension of product circulation
Suspension of supply to the violating entity
Seizure or destruction of non-compliant medicines
Financial penalties and corrective action plans

Incorrect data, missing events, or system misuse can trigger enforcement actions even if products are physically serialized.

Key Takeaway for Pharma Companies

Egypt’s pharmaceutical track and trace system is designed for continuous visibility and regulatory control. Compliance depends not only on packaging codes, but on system integration, data accuracy, and operational discipline.For companies manufacturing in, importing to, or exporting into Egypt, traceability readiness must be addressed early—across Quality, Regulatory, IT, and Supply Chain teams—to avoid disruptions once enforcement begins.

This article is written by SoftGroup’s regulatory and serialization experts, with hands-on experience supporting pharmaceutical companies implementing national track and trace systems across MENA, EU, and CIS markets.

If your organization is preparing for Egypt’s 2026 serialization deadlines, ensuring EPCIS readiness and data accuracy early can prevent delays once enforcement begins. Contact SoftGroup experts!